期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 20, 期 23, 页码 6885-6893出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2012.09.026
关键词
Azanucleosides; Synthesis; Anti-HIV-1; Anti-HCV; L-Pyroglutamic acid
资金
- Spanish Ministerio de Educacion y Ciencia (MEC) [MEC-CTQ-2007-61126]
- PCTI [EQUIP09-07]
- MEC
- National Institutes of Health (NIH) [R01 GM081484]
- National Science Foundation [CHE9709183, CHE0741968]
- NIH [2P30-AI-050409]
- Department of Veterans Affairs
A series of 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides of both pyrimidine and purine nucleobases were synthesized in an efficient manner starting from commercially available L-pyroglutamic acid via glycosylation of difluorinated pyrrolidine derivative 15. Several 4'-azanucleosides were prepared as a separable mixture of alpha- and beta-anomers. The 6-chloropurine analogue was obtained as a mixture of N-7 and N-9 regioisomers and their structures were identified based on NOESY and HMBC spectral data. Among the 4'-azanucleosides tested as HIV-1 inhibitors in primary human lymphocytes, four compounds showed modest activity and the 5-fluorouracil analogue (18d) was found to be the most active compound (EC50 = 36.9 mu M) in this series. None of the compounds synthesized in this study demonstrated anti-HCV activity. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据